Effects of the food additive monosodium glutamate on cisplatin-induced gastrointestinal dysmotility and peripheral neuropathy in the rat
- PMID: 33112027
- DOI: 10.1111/nmo.14020
Effects of the food additive monosodium glutamate on cisplatin-induced gastrointestinal dysmotility and peripheral neuropathy in the rat
Abstract
Background: Cisplatin is an antineoplastic drug known to produce intense vomiting, gastric dysmotility, and peripheral neuropathy. Monosodium glutamate (MSG) is a flavor enhancer with prokinetic properties potentially useful for cancer patients under chemotherapy. Our aim was to test whether MSG may improve gastrointestinal motor dysfunction and other adverse effects induced by repeated cisplatin in rats.
Methods: Male Wistar rats were exposed or not to MSG (4 g L-1 ) in drinking water from week 0 to 1 week after treatment. On the first day of weeks 1-5, rats were treated with saline or cisplatin (2 mg kg-1 week-1 , ip). Gastrointestinal motility was measured by radiological methods after first and fifth administrations, as well as 1 week after treatment finalization. One week after treatment, the threshold for mechanical somatic sensitivity was recorded. Finally, samples of stomach, terminal ileum and kidneys were evaluated in sections using conventional histology. The myenteric plexus was immunohistochemically evaluated on distal colon whole-mount preparations.
Key results: Monosodium glutamate prevented the development of cisplatin-induced neuropathy and partially improved intestinal transit after the fifth cisplatin administration with little impact on gastric dysmotility. MSG did not improve the histological damage of gut wall, but prevented the changes induced by cisplatin in the colonic myenteric plexus.
Conclusion and inferences: Our results suggest that MSG can improve some dysfunctions caused by anticancer chemotherapy in the gut and other systems, associated, at least partially, with neuroprotectant effects. The potentially useful adjuvant role of this food additive to reduce chemotherapy-induced sequelae warrants further evaluation.
Keywords: cisplatin; gastric emptying; intestinal transit; monosodium glutamate; myenteric; peripheral neuropathy; rat.
© 2020 John Wiley & Sons Ltd.
Similar articles
-
Effects of vincristine and monosodium glutamate on gastrointestinal motility and visceral sensitivity.Neurogastroenterol Motil. 2024 Jan;36(1):e14704. doi: 10.1111/nmo.14704. Epub 2023 Nov 14. Neurogastroenterol Motil. 2024. PMID: 37964110
-
Enteric neuropathy evoked by repeated cisplatin in the rat.Neurogastroenterol Motil. 2011 Apr;23(4):370-8, e162-3. doi: 10.1111/j.1365-2982.2011.01674.x. Epub 2011 Feb 7. Neurogastroenterol Motil. 2011. PMID: 21299719
-
Cisplatin-induced gastrointestinal dysmotility is aggravated after chronic administration in the rat. Comparison with pica.Neurogastroenterol Motil. 2010 Jul;22(7):797-805, e224-5. doi: 10.1111/j.1365-2982.2010.01483.x. Epub 2010 Mar 12. Neurogastroenterol Motil. 2010. PMID: 20236245
-
[Numerical Evaluation of Efficacy of Glutamate on Gastrointestinal Motility: Rapid MRI Study].Yakugaku Zasshi. 2016;136(10):1345-1354. doi: 10.1248/yakushi.16-00057-3. Yakugaku Zasshi. 2016. PMID: 27725383 Review. Japanese.
-
Gastrointestinal motility and functional gastrointestinal diseases.Curr Pharm Des. 2014;20(16):2775-82. doi: 10.2174/13816128113199990572. Curr Pharm Des. 2014. PMID: 23886379 Review.
Cited by
-
Contractility of isolated colonic smooth muscle strips from rats treated with cancer chemotherapy: differential effects of cisplatin and vincristine.Front Neurosci. 2023 Dec 18;17:1304609. doi: 10.3389/fnins.2023.1304609. eCollection 2023. Front Neurosci. 2023. PMID: 38192512 Free PMC article.
-
Based on network pharmacology and molecular docking to explore the protective effect of Epimedii Folium extract on cisplatin-induced intestinal injury in mice.Front Pharmacol. 2022 Oct 12;13:1040504. doi: 10.3389/fphar.2022.1040504. eCollection 2022. Front Pharmacol. 2022. PMID: 36313368 Free PMC article.
-
Effects of Repeated Cisplatin and Monosodium Glutamate on Visceral Sensitivity in Rats.Cells. 2024 Dec 30;14(1):26. doi: 10.3390/cells14010026. Cells. 2024. PMID: 39791727 Free PMC article.
References
REFERENCES
-
- Schwartzberg LS. Chemotherapy-induced nausea and vomiting: clinician and patient perspectives. J Support Oncol. 2007;5(2 Suppl 1):5-12.
-
- Navari RM. Prevention of emesis from multiple-day and high-dose chemotherapy regimens. J Natl Compr Canc Netw. 2007;5(1):51-59.
-
- Markman M. Chemotherapy-induced peripheral neuropathy: underreported and underappreciated. Curr Pain Headache Rep. 2006;10(4):275-278.
-
- Van Cutsem E, Arends J. The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs. 2005;9(Suppl 2):S51-S63.
-
- Nurgali K, Jagoe RT, Abalo R. Editorial: adverse effects of cancer chemotherapy: anything new to improve tolerance and reduce sequelae? Front Pharmacol. 2018;22(9):245. https://doi.org/10.3389/fphar.2018.00245
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical